MorphoSys Appoints New Head of Research Antibody Business

MorphoSys AG (Martinsreid/Munich) has appointed Dieter Feger to head its AbD Serotec business for research and diagnostic antibodies. He joins the company from Abbott Diagnostics, where he was of Marketing Director - Global Marketing for the past four years most recently with

responsibility for Infectious Diseases, Abbott Diagnostics’ biggest reagent franchise. Prior to that, he spent 18 years with Abbott in Europe, in a variety of roles before moving to the US. He replaces Dieter Lingelbach who has left MorphoSys to pursue new opportunities.

"I am delighted to welcome Dieter Feger to the management team of MorphoSys. He brings deep experience from his work at Abbott Diagnostics, one of the industry’s leading companies, that will assist AbD Serotec to seek new growth opportunities and to expand its footprint in the diagnostics industry," commented Dr Simon Moroney, Chief Executive Officer of MorphoSys AG. "I would like to thank Dieter Lingelbach for his

invaluable contribution to establishing AbD Serotec as a leading supplier of research antibodies and wish him well in the future."